Webinars

Matteo Bassetti, Professor of Infectious Diseases, University of Genoa and Philippe Montravers, Head of the Department of Anaesthesia and Critical Care Medicine Unit, at Assistance Publique Hospitaux Paris, present risk stratification in infectious diseases and its role in achieving a truly patient-centric approach.

David Jenkins, Consultant Medical Microbiologist, University Hospital of Leicester and Dr Maha Albur, Consultant Physician Infectious Disease and Microbiology North Bristol NHS Trust present the evolving Gram-negative resistance landscape in the UK, and share their experience on managing an OXA-48 outbreak.

Professor Antoni Torres, Department of Pulmonology and Respiratory Allergy, Clinic of Barcelona, Spain, shares his experience in treating HAP/VAP in critically ill patients, discusses the importance of identifying risk factors and using local epidemiology patterns to enable early adequate therapy.

Dr Luke Moore, Infectious Diseases Consultant at Chelsea and Westminster, presents the importance of risk stratification and screening for resistant Gram-negative infections.

Dr Louise Sweeney, Consultant Clinical Microbiologist, presents the management of difficult-to-treat bacterial infections, resistance patterns including her experience on managing resistance in Manchester.

David Jenkins, Consultant Medical Microbiologist, University Hospital of Leicester discusses resistance mechanisms and outbreaks in the UK. He explores the evolving Gram-negative resistance landscape in the UK, shares his experience of an OXA-48 outbreak and the importance of avoiding outbreaks through effective antimicrobial stewardship.

Dr Andrew Dodgson, Consultant Microbiologist at Manchester, presents his perspective on early effective intervention in critically ill patients with MDR Gram-negative infections.

Dr Luke Moore and Miguel Sanchez Garcia discuss clinical effectiveness of ZAVICEFTA in treating severe Gram-negative infections.